NeurologyLive Friday 5 — May 29, 2020


Take 5 minutes to catch up on NeurologyLive's highlights from the week ending May 29, 2020.

Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: CMSC 2020 Day 1: Peter Calabresi, MD, on CNS Immune Responses in Progressive MS

Peter Calabresi, MD, delivers the Whitaker Lecture as part of the 2020 CMSC Virtual Annual Meeting.


2: CMSC 2020 Day 2: Brenda Banwell, MD, on Current Perspectives of Pediatric MS Care and Research

Brenda Banwell, MD, presents her lecture titled, "Current Perspectives of Pediatric MS Care and Research" as part of the 2020 CMSC Virtual Annual Meeting.


3: Shadi Yaghi, MD: Incidence of Stroke in Patients With COVID-19

The assistant professor and director of Clinical Vascular Neurology Research at NYU Langone gives perspective on his recent study of patients with stroke and COVID-19 and the difficulties in understanding their relationship.


4: Ocrelizumab Has Similar Effects in MS With Shorter Infusion Time

The Genentech agent, which is approved for patients with relapsing-remitting multiple sclerosis, showed no new safety signals in a comparison between conventional and shorter infusion times.


5: Reviewing a Case of Parkinson Disease OFF Episodes

Peter A. LeWitt, MD, offers expert perspective on the identification and management of OFF episodes in a 68-year-old man with Parkinson disease.


Related Videos
Ro'ee Gilron, PhD
Monica Verduzco-Gutierrez, MD
Shahid Nimjee, MD, PhD
Peter J. McAllister, MD, FAAN
Video 6 - "Utilization of Neuroimaging in Alzheimer’s Disease"
Video 5 - "Contribution of Multiple Pathways to the Development of Alzheimer’s Disease"
Michael Levy, MD, PhD
Michael Levy, MD, PhD
© 2024 MJH Life Sciences

All rights reserved.